EXHIBIT 3.8

                            CERTIFICATE OF CORRECTION

                                       OF

                            CERTIFICATE OF AMENDMENT

                                       OF

                          CERTIFICATE OF INCORPORATION

                                       OF

                       NASTECH PHARMACEUTICAL COMPANY INC.

            NASTECH PHARMACEUTICAL COMPANY INC., a Delaware corporation (the
"Corporation"), pursuant to Section 103(f) of the Delaware General Corporation
Law (the "DGCL"), hereby certifies as follows:

            FIRST: The document evidencing the Certificate of Amendment of
Certificate of Incorporation of NASTECH PHARMACEUTICAL COMPANY INC. filed with
the Secretary of State of the State of Delaware on November 8, 1993 (the
"Document") is an inaccurate record of the corporate action referred to therein.

            SECOND: The Document is inaccurate in that the language set forth in
Article FOURTH was not the language approved by the stockholders of the
Corporation.

            THIRD: Article FOURTH in its correct form is as follows:

            "FOURTH: (a) The Corporation shall be authorized to issue the
      following shares:



Class                   Number of Shares                     Par Value
- -----                   ----------------                     ---------
                                                       
Common                      6,000,000                          $.006
Preferred                     100,000                          $ .01


            The 4,886,171 issued and outstanding shares of the Corporation's
      Common Stock, $.002 par value, are hereby changed, converted and
      reconstituted into 1,628,723 issued and outstanding shares of the
      Corporation's Common Stock, $.006 par value.

            (b) The designations and the powers, preferences, rights and the
      qualifications or restrictions thereof are as follows:



            The Board of Directors of the Corporation is authorized from time to
      time to issue, without additional authority from the Corporation's
      shareholders, all or any part of the above authorized Preferred Stock, par
      value one cent ($.01) per share, and in connection therewith by resolution
      or resolutions providing for the issue of shares thereof, to divide into
      series any portion of or all of the Preferred Stock, to fix the number of
      shares constituting such series, and to fix the stated value, fix or alter
      the voting rights, dividend rights, dividend rates, conversion rights,
      powers preferences, rights and terms of redemption, rights upon
      dissolution or liquidation, and any other special rights, qualifications,
      limitations, or restrictions of the shares of Preferred Stock of any such
      series thereof to the full extent now or hereafter permitted by the laws
      of the State of Delaware."

                                       2


            IN WITNESS WHEREOF, the Corporation has caused this Certificate of
Correction to be signed by its duly authorized officer this 28th day of July,
2004.

                                       NASTECH PHARMACEUTICAL COMPANY INC.

                                       By: /s/ GREGORY L. WEAVER
                                           ---------------------------
                                           Gregory L. Weaver
                                           Secretary and Chief Financial Officer

                                       3